Extrachromosomal DNA directed therapy - Boundless Bio
Alternative Names: ecDTx 3 directed tharepy; Extrachromosomal DNA segregation inhibitor therapeutics - Boundless BioLatest Information Update: 07 Sep 2023
At a glance
- Originator Boundless Bio
- Class Antineoplastics
- Mechanism of Action Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 26 Jul 2023 Early research in Cancer in USA (unspecified route) (Boundless Bio pipeline, prior to July 2023)